The world is getting older. Not only geologically, but also anagraphically. And as the median life expectancy at birth increases, those of us that are alive are sleeping less. Public health institutions worldwide have, in fact, diagnosed epidemics of insomnia. These two factors are contributing to an increase in comorbidity in those affected by Complex Brain Disorders (CoBraD) such as Neurocognitive Dementia (i.e. Alzheimer’s Disease) and Epilepsy.
Despite technological progress and advances in medical sciences, we are still unable to pinpoint the exact cause of these disorders and, thus, to solve them at scale. But today, thanks to the vast availability of clinical and consumer data from multiple, real world sources, it is possible to develop a novel, AI-based Multidisciplinary Expert System (MES) for improving diagnostic accuracy and therapeutic outcomes for those suffering from CoBraD.
The project aims to develop such a technology and test it in a series of pilots in EEA countries. Patients who participate will share personal and highly sensitive data, which will be collected and processed necessarily by the AI system.
Throughout this process, CyberEthics Lab. will support the consortium in dealing with multidisciplinary concerns, which the project unequivocally raises, by issuing and seeing enforced ethical guidelines for the research process. Furthermore, through its proprietary methodology that combines ethical and legal approaches, CyberEthics Lab. aims to verify whether the project’s technologies are in line with existing regulations and therefore to contribute to the development of a standard for the ethics of AI in health care research. Thanks to its holistic approach and technological know-how, CyberEthics Lab. will create a helpdesk for the project and also assess its sex and gender impacts.